Which has the lower trailing P/E, HALO or JAZZ?

JAZZ has the lower trailing P/E: HALO trades at 32.75 and JAZZ at 15.82. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HALO or JAZZ?

Over the past five years, HALO grew revenue faster — HALO at a 32.18% CAGR versus JAZZ at 11.87%.

Is HALO or JAZZ more profitable?

HALO runs the higher net margin — HALO at 24.86% versus JAZZ at 20.45%.

How have HALO and JAZZ total returns compared?

Over the past 10 years, HALO delivered 24.30% and JAZZ delivered 6.58% annualized total return. Past performance doesn't predict future results.

Halozyme Therapeutics, Inc. (HALO) vs Jazz Pharmaceuticals plc (JAZZ)

A side-by-side comparison of Halozyme Therapeutics, Inc. and Jazz Pharmaceuticals plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HALO

Halozyme Therapeutics, Inc.

$13.01B

$109.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

JAZZ

Jazz Pharmaceuticals plc

$14.54B

$231.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — HALO vs JAZZ

growth of $100 · dividends reinvested · last 10y

HALO +779.9% (+24.3%/yr)JAZZ +91.9% (+6.7%/yr)HALO compounded faster over this window

HALO JAZZ

HALO vs JAZZ: by the numbers

•JAZZ is the larger company ($14.54B vs $13.01B market cap).
•JAZZ trades at the lower trailing earnings multiple (15.82 vs 32.75 P/E), one valuation lens rather than an overall verdict.
•HALO converts more revenue to profit (24.86% vs 20.45% net margin).
•HALO grew revenue faster over the past five years (32.18% vs 11.87% CAGR).

Metrics side by side

Valuation

Metric	HALO	JAZZ
P/E ratio	32.75	15.82
Forward P/E	13.04	9.27
PEG ratio	1.43	N/A
P/S ratio	7.82	3.16
P/B ratio	90.66	3.03
EV / EBITDA	14.22	8.74
FCF yield	6.19%	10.61%

Profitability

Metric	HALO	JAZZ
Gross margin	78.18%	84.67%
Operating margin	56.77%	5.26%
Net margin	24.86%	20.45%
ROE	288.13%	19.59%
ROIC	27.42%	14.48%

Growth (annualized)

Metric	HALO	JAZZ
Revenue CAGR (5Y)	32.18%	11.87%
EPS CAGR (5Y)	22.68%	N/A
FCF CAGR (5Y)	40.08%	15.39%
Total return CAGR (5Y)	22.18%	13.01%

Frequently asked

Which has the lower trailing P/E, HALO or JAZZ?: JAZZ has the lower trailing P/E: HALO trades at 32.75 and JAZZ at 15.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HALO or JAZZ?: Over the past five years, HALO grew revenue faster — HALO at a 32.18% CAGR versus JAZZ at 11.87%.
Is HALO or JAZZ more profitable?: HALO runs the higher net margin — HALO at 24.86% versus JAZZ at 20.45%.
How have HALO and JAZZ total returns compared?: Over the past 10 years, HALO delivered 24.30% and JAZZ delivered 6.58% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HALO analysis Full JAZZ analysis Interactive comparison tool

Dig into the metrics

Halozyme Therapeutics P/E ratio Jazz Pharmaceuticals P/E ratio Halozyme Therapeutics ROE Jazz Pharmaceuticals ROE Halozyme Therapeutics operating margin Jazz Pharmaceuticals operating margin Halozyme Therapeutics revenue growth Jazz Pharmaceuticals revenue growth Halozyme Therapeutics free cash flow Jazz Pharmaceuticals free cash flow

Halozyme Therapeutics & Jazz Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.